quinazolines has been researched along with Substance Withdrawal Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blendy, JA; Everett, L; Jepson, C; Kaestner, KH; Lee, B; Lerman, C; Ray, R; Turner, JR; Xiang, J | 1 |
| Chan, FL; Chang, C; Huang, J; Lee, YF; Lin, WJ; Messing, EM; Wilding, G | 1 |
| Allison, C; Pratt, JA; Ripley, TL; Stephens, DN | 1 |
| Allison, C; Pratt, JA | 1 |
| Burden, AC; Pohl, JE | 1 |
| Ebert, U; Hönack, D; Löscher, W; Rundfeldt, C | 1 |
| Brain, SD; Hill, RG; Poyner, DR | 1 |
7 other study(ies) available for quinazolines and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.
Topics: Adolescent; Adult; Afatinib; Aged; Animals; Behavior, Animal; Cyclic AMP Response Element-Binding Protein; DNA; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Hippocampus; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Middle Aged; Mutation; Neuregulins; Nicotine; Polymorphism, Single Nucleotide; Quinazolines; Rats; Receptor, ErbB-4; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; White People; Young Adult | 2014 |
Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Topics: Androgen Antagonists; Cell Division; Cyclin D1; Enzyme Activation; ErbB Receptors; Flutamide; Humans; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasms, Hormone-Dependent; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-raf; Quinazolines; ras Proteins; Receptors, Androgen; Substance Withdrawal Syndrome; Tyrphostins | 2002 |
alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate receptor autoradiography in mouse brain after single and repeated withdrawal from diazepam.
Topics: Animals; Autoradiography; Brain; Brain Mapping; Diazepam; Drug Administration Schedule; GABA Modulators; Imidazoles; Male; Mice; Mice, Inbred C57BL; Protein Binding; Quinazolines; Receptors, AMPA; Substance Withdrawal Syndrome; Time Factors; Tissue Distribution; Tritium | 2005 |
Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics.
Topics: Animals; Anxiety; Autoradiography; Diazepam; Excitatory Amino Acid Antagonists; Hypnotics and Sedatives; Imidazoles; In Situ Hybridization; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Oligonucleotide Probes; Quinazolines; Rats; Rats, Long-Evans; Receptors, AMPA; RNA, Messenger; Substance Withdrawal Syndrome | 2006 |
Withdrawing vasodilators.
Topics: Heart Failure; Humans; Prazosin; Quinazolines; Substance Withdrawal Syndrome | 1980 |
Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. II. The novel imidazoquinazolines NNC 14-0185 and NNC 14-0189.
Topics: Animals; Anticonvulsants; Body Temperature; Drug Tolerance; GABA-A Receptor Agonists; Male; Mice; Motor Activity; Quinazolines; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Gene Transfer, Horizontal; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Knockout; Migraine Disorders; Piperazines; Quinazolines; Rabbits; Receptor Activity-Modifying Proteins; Receptors, Calcitonin Gene-Related Peptide; Species Specificity; Substance Withdrawal Syndrome | 2002 |